- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Shionogi's RSV antiviral reduces viral load in phase 2 trial of adults | 4 | FierceBiotech | ||
| 17.01. | Shionogi awarded $375m from HHS for preventative Covid-19 injectable | 2 | Pharmaceutical Technology | ||
| SHIONOGI & CO LTD ADR Aktie jetzt für 0€ handeln | |||||
| 19.12.24 | Nxera Pharma and Shionogi Launch QUVIVIQ in Japan for Adults with Insomnia | 14 | GlobeNewswire (USA) | ||
| 29.10.24 | Shionogi's Xocova effective in preventing symptomatic COVID-19: study | 6 | Seeking Alpha | ||
| 29.10.24 | Shionogi & Co. reports Q2 results | 9 | Seeking Alpha | ||
| 01.10.24 | Nxera Pharma Enters New Commercial Partnership with Shionogi for QUVIVIQ in Japan | 280 | GlobeNewswire (Europe) | QUVIVIQ is a potential best-in-class treatment in the high-growth, dual orexin antagonist class of medicines treating sleep disorders, such as insomnia Tokyo, Japan and Cambridge, UK, 1 October 2024... ► Artikel lesen | |
| 09.05.24 | Global Health Innovative Technology Fund (GHIT Fund): Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions | 1.188 | PR Newswire | TOKYO, May 9, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.64 billion (USD 10.8 million1) in four projects... ► Artikel lesen |
7 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TRULIEVE CANNABIS | 4,814 | +4,02 % | Trulieve Cannabis Corp: Trulieve to open medical dispensary in Palm Coast | ||
| WEST PHARMACEUTICAL SERVICES | 326,80 | +0,18 % | West Pharmaceutical legt Dividende für das erste Quartal auf 0,21 US-Dollar pro Aktie fest | ||
| SHIONOGI | 14,600 | +2,10 % | Shionogi's RSV antiviral reduces viral load in phase 2 trial of adults | ||
| KALA BIO | 8,490 | +1,19 % | KALA BIO, Inc. (NASDAQ:KALA) CFO Sells $13,016.78 in Stock | ||
| HERITAGE CANNABIS | 0,001 | 0,00 % | Heritage Cannabis Holdings Corp.: Heritage Cannabis Announces Completion of Sale and Delisting from the CSE and the OTCQX | TORONTO, Aug. 29, 2024 /CNW/ - Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) ("Heritage" or the "Company") today announces, that, in connection with its creditor protection proceedings... ► Artikel lesen | |
| CHARLOTTES WEB | 0,096 | -1,04 % | Charlotte's Web Holdings, Inc.: Charlotte's Web Reports 2024 Third quarter Financial Results | Sequential quarterly growth returns for 2024 New Product Innovations Driving Omni-Channel Expansion
LOUISVILLE, Colo., Nov. 14, 2024 /PRNewswire/ - (TSX: CWEB... ► Artikel lesen | |
| BEXIMCO | 0,450 | 0,00 % | Beximco Pharma. - Payment of Cash Dividend | ||
| LUYE PHARMA | 0,256 | -4,48 % | LUYE PHARMA (02186): VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED FOR THE PHASE 2 CLINICAL STUDY OF THE GROUP'S NEW DRUG LY03015 IN CHINA | ||
| MIRUM PHARMACEUTICALS | 46,200 | -0,86 % | Mirum Pharmaceuticals: Führungskraft verkauft Aktien im Wert von 43.227 US-Dollar | ||
| GUARDION HEALTH SCIENCES | 2,740 | 0,00 % | Guardion Health Sciences, Inc.: Guardion Health Sciences Announces Filing of Certificate of Dissolution | HOUSTON, TEXAS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) ("Guardion" or the "Company") today announced that it has filed a certificate of dissolution with the... ► Artikel lesen | |
| PERCHERON THERAPEUTICS | 0,004 | -12,50 % | PERCHERON THERAPEUTICS LIMITED: Quarterly Activities Report and Appendix 4C | ||
| AYURCANN | 0,013 | 0,00 % | Ayurcann Holdings Corp.: Ayurcann Terminates Business Combination | Toronto, Ontario, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) ("Ayurcann" or the "Company"), a leading Canadian processing and manufacturing company specializing... ► Artikel lesen | |
| EVEREST MEDICINES | 5,050 | +2,23 % | Everest Medicines Limited: Everest Medicines Announces the Implementation of NEFECON National Reimbursement Drug List Pricing in China for the Treatment for IgA Nephropathy | SHANGHAI, Jan 2, 2025 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK, Everest, or the 'Company'), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization... ► Artikel lesen | |
| KALBE FARMA | 0,066 | 0,00 % | KLBF strengthens prescription drug business by inaugurating radioisotope factory: PT Kalbe Farma Tbk ... | ||
| AVANT BRANDS | 0,715 | -10,06 % | Avant Brands Inc.: Avant Brands Announces Results for Q3 2024 | Record Gross and Net Revenue: Generated $9.6 million Gross Revenue and $8.5 million Net Revenue in Q3 2024, establishing new company records.Record Export Wholesale Revenue1: Generated $5.1 million... ► Artikel lesen |
Das Unternehmen SHIONOGI & CO LTD ADR kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 6,850 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHIONOGI & CO LTD ADR finden Sie auf Wallstreet Online.
